HIF-1α/VEGF signaling pathway may play a dual role in secondary pathogenesis of cervical myelopathy

Medical Hypotheses

Volumn 79, Issue 1, 2012, Pages 82-84

  Long, Hou Qing ^a   Li, Guang Sheng ^a   Hu, Yong ^b   Wen, Chun Yi ^b   Xie, Wen Han ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ARACHIDONIC ACID; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RECOMBINANT VASCULOTROPIN; VASCULOTROPIN; VASCULOTROPIN 165;

ANGIOGENESIS; ARTICLE; BINDING KINETICS; BLOOD FLOW; BLOOD SPINAL CORD BARRIER; BLOOD VESSEL; CELL INFILTRATION; CELL PROLIFERATION; CERVICAL MYELOPATHY; CONTUSION; CORRELATION ANALYSIS; DISEASE EXACERBATION; DRUG MEGADOSE; ENDOTHELIUM CELL; EXCITOTOXICITY; GRAY MATTER; LEUKOCYTE; LIPID PEROXIDATION; LOCOMOTION; LOW DRUG DOSE; MEMBRANE PERMEABILITY; MICROENVIRONMENT; MICROINJECTION; MICROVASCULATURE; MOTOR PERFORMANCE; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; OXYGEN TRANSPORT; PATHOGENESIS; PERMEABILITY BARRIER; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; UPREGULATION; VASCULAR ENDOTHELIUM; WHITE MATTER;

CERVICAL VERTEBRAE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MODELS, THEORETICAL; SIGNAL TRANSDUCTION; SPINAL CORD DISEASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA;

EID: 84861456201     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.04.006     Document Type: Article

References (26)

1. McCormick W.E., Steinmetz M.P., Benzel E.C. Cervical spondylotic myelopathy: make the difficult diagnosis, then refer for surgery. Cleve Clin J Med 2003, 70:899-904.
2. Hu Y., Wen C.Y., Li T.H., Cheung M.M., Wu E.X., Luk K.D. Somatosensory-evoked potentials as an indicator for the extent of ultrastructural damage of the spinal cord after chronic compressive injuries in a rat model. Clin Neurophysiol 2011, 122(7):1440-1447.
3. Vangeison G., Carr D., Federoff H.J., Rempe D.A. The good, the bad, and the cell type-specific roles of hypoxia inducible factor-1 alpha in neurons and astrocytes. J Neurosci 2008, 28(8):1988-1993.
4. Bergeron M., Yu A.Y., Solway K.E., Semenza G.L., Sharp F.R. Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur J Neurosci 1999, 11(12):4159-4170.
5. Widenfalk J., Lipson A., Jubran M., et al. Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury. Neuroscience 2003, 120(4):951-960.
6. Kim H.M., Hwang D.H., Lee J.E., Kim S.U., Kim B.G. Ex vivo VEGF delivery by neural stem cells enhances proliferation of glial progenitors, angiogenesis, and tissue sparing after spinal cord injury. PLoS One 2009, 4:e4987.
7. Benton R.L., Whittemore S.R. VEGF165 therapy exacerbates secondary damage following spinal cord injury. Neurochem Res 2003, 28(11):1693-1703.
8. Patel C.B., Cohen D.M., Ahobila-Vajjula P., Sundberg L.M., Chacko T., Narayana P.A. Effect of VEGF treatment on the blood-spinal cord barrier permeability in experimental spinal cord injury: dynamic contrast-enhanced magnetic resonance imaging. J Neurotrauma 2009, 26:1005-1016.
9. Levy A.P., Levy N.S., Wegner S., Goldberg M.A. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 1995, 270:13333-13340.
10. Kimura H., Weisz A., Ogura T., et al. Identification of hypoxia-inducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide. J Biol Chem 2001, 276:2292-2298.
11. Brockington A., Lewis C., Wharton S., Shaw P.J. Vascular endothelial growth factor and the nervous system. Neuropathol Appl Neurobiol 2004, 30:427-446.
12. Murakami T., Ilieva H., Shiote M., et al. Hypoxic induction of vascular endothelial growth factor is selectively impaired in mice carrying the mutant SOD1 gene. Brain Res 2003, 989:231-237.
13. Nordal R.A., Nagy A., Pintilie M., Wong C.S. Hypoxia and hypoxia-inducible factor-1 target genes in central nervous system radiation injury: a role for vascular endothelial growth factor. Clin Cancer Res 2004, 10:3342-3353.
14. Choi J.S., Kim H.Y., Cha J.H., et al. Upregulation of vascular endothelial growth factor receptors Flt-1 and Flk-1 following acute spinal cord contusion in rats. J Histochem Cytochem 2007, 55:821-830.
15. Sharma H.S. Pathophysiology of blood-spinal cord barrier in traumatic injury and repair. Curr Pharm Des 2005, 11:1353-1389.
16. Xiaowei H., Ninghui Z., Wei X., Yiping T., Linfeng X. The experimental study of hypoxia-inducible factor-1 alpha and its target genes in spinal cord injury. Spinal Cord 2006, 44:35-43.
17. Herrera J.J., Sundberg L.M., Zentilin L., Giacca M., Narayana P.A. Sustained expression of vascular endothelial growth factor and angiopoietin-1 improves blood-spinal cord barrier integrity and functional recovery after spinal cord injury. J Neurotrauma 2010, 27(11):2067-2076.
18. Kasahara K., Nakagawa T., Kubota T. Neuronal loss and expression of neurotrophic factors in a model of rat chronic compressive spinal cord injury. Spine (Phila Pa 1976) 2006, 31(18):2059-2066.
19. Herrera J.J., Nesic O., Narayana P.A. Reduced vascular endothelial growth factor expression in contusive spinal cord injury. J Neurotrauma 2009, 26(7):995-1003.
20. Liu Y., Figley S., Spratt S.K., et al. An engineered transcription factor which activates VEGF-A enhances recovery after spinal cord injury. Neurobiol Dis 2010, 37:384-393.
21. al-Mefty O., Harkey H.L., Marawi I., et al. Experimental chronic compressive cervical myelopathy. J Neurosurg 1993, 79:550-561.
22. Rosenstein J.M., Krum J.M. New roles for VEGF in nervous tissue - beyond blood vessels. Exp Neurol 2004, 187:246-253.
23. van Neerven S., Joosten E.A., Brook G.A., et al. Repetitive intrathecal VEGF(165) treatment has limited therapeutic effects after spinal cord injury in the rat. J Neurotrauma 2010, 27:1781-1791.
24. Svensson B., Peters M., Konig H.G., et al. Vascular endothelial growth factor protects cultured rat hippocampal neurons against hypoxic injury via an antiexcitotoxic, caspase-independent mechanism. J Cereb Blood Flow Metab 2002, 22:1170-1175.
25. Kaya D., Gursoy-Ozdemir Y., Yemisci M., Tuncer N., Aktan S., Dalkara T. VEGF protects brain against focal ischemia without increasing blood-brain permeability when administered intracerebroventricularly. J Cereb Blood Flow Metab 2005, 25:1111-1118.
26. Cariboni A., Davidson K., Dozio E., et al. VEGF signalling controls GnRH neuron survival via NRP1 independently of KDR and blood vessels. Development 2011, 138(17):3723-3733.